Health & Medicine

6

Vatican, University of Maryland Enter Stem Cell Research Partnership

April 23, 2010

John Gearhart of the School of Veterinary Medicine and the School of Medicine discusses a Vatican-sponsored stem-cell research study.

Article Source: Baltimore Sun

The Times and Trials of Dr. Ahmed

April 25, 2010

John Stanley of the School of Medicine comments on the application of the anti-blistering drug IVIG.

Article Source: Boston Globe

Video: Is Using Adderall Like Using Steroids?

April 25, 2010

Arthur Caplan of the School of Medicine discusses the ethics of brain-enhancing drugs.

Article Source: “60 Minutes” (CBS)

Video: Boosting Brain Power

April 25, 2010

Martha Farah of the School of Arts and Sciences says brain-enhancing drugs will one day be the norm.

Article Source: “60 Minutes” (CBS)

Smart Pills a Smart Idea, Penn Prof Tells ‘60 Minutes’

April 26, 2010

Martha Farah of the School of Arts and Sciences says brain enhancers can benefit society.

Article Source: Philadelphia Inquirer

Video: Debating the Ethics of Rationing End-of-Life Care

April 26, 2010

Arthur Caplan of the School of Medicine joins a debate forum to discuss end-of-life health-care rationing.

Article Source: “PBS NewsHour”

Prostate Cancer Vaccine

April 26, 2010

Naomi Haas of the School of Medicine comments on new prostate-cancer treatment Provenge.

Article Source: KYW-TV (Philadelphia)

'The Vaccine Wars' on PBS

April 27, 2010

Arthur Caplan of the School of Medicine says "one of the bitter ironies of vaccination is it carries with it the problems of its own success.”

Article Source: Los Angeles Times

Can an Old Head Injury Suddenly Cause Detrimental Effects Much Later in Life?

April 13, 2010

Douglas Smith of the School of Medicine authors a column on head trauma.

Article Source: Scientific American
facebook twitter google print email
Media Contact:Jordan Reese | jreese@upenn.edu | 215-573-6604April 21, 2010

Gene Therapy Cures Canines of Inherited Form of Day Blindness, Penn Veterinary Researchers Say

PHILADELPHIA –- Veterinary ophthalmology researchers from the University of Pennsylvania have used gene therapy to restore retinal cone function and day vision in two canine models of congenital achromatopsia, also called rod monochromacy or total color blindness.